Serum glycated albumin is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents: An observational study

BACKGROUND: Previous studies have confirmed the predicted value of serum glycated albumin (GA) in atherosclerotic cardiovascular disease. However, the relationship between GA and the development of in-stent restenosis (ISR) after drug-eluting stent (DES) implantation has not been verified in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Xiao Long, Li, Qiu Yu, Zhao, Dong Hui, Liu, Jing Hua, Fan, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551162/
https://www.ncbi.nlm.nih.gov/pubmed/36237913
http://dx.doi.org/10.3389/fcvm.2022.943185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551162/
https://www.ncbi.nlm.nih.gov/pubmed/36237913
http://dx.doi.org/10.3389/fcvm.2022.943185

Ejemplares similares